Wed Sep 25 09:00:00 UTC 2024: ## Precision Medicine Holds Promise for Preventing Pregnancy Complications
**A new wave of innovation is emerging to tackle the alarming trend of near-miss emergencies in pregnancy, aiming to prevent life-threatening complications and ensure a safer experience for expectant mothers.**
Breana Williams’ story, a first-time mother who faced preeclampsia and placental abruption, highlights the serious reality of near-misses during pregnancy. While she and her baby thankfully recovered, her experience is sadly not unique. Every year, thousands of women in the U.S. endure life-threatening complications during pregnancy, delivery, or postpartum.
These near misses, often caused by conditions like preeclampsia, preterm birth, and severe hemorrhaging, carry a heavy emotional and financial toll. Families are disrupted, and the burden on the healthcare system is significant, exceeding $30 billion in 2019 alone.
Dr. Maneesh Jain, cofounder and CEO of Mirvie, argues that the current approach to prenatal care is outdated and ineffective. “We still use a prenatal care paradigm…developed nearly 100 years ago,” he explains. “If we can biologically understand who’s at risk early in pregnancy and apply preventive care, we have a significantly improved opportunity to prevent preeclampsia or mitigate the severity of the disease.”
Mirvie’s innovative solution utilizes RNA testing to predict preeclampsia months before symptoms appear. This allows for early intervention, potentially preventing or mitigating the severity of the condition.
Dr. Jain emphasizes the importance of a paradigm shift towards precision medicine in pregnancy healthcare. He believes that groundbreaking solutions like RNA testing can help create a safer and more joyful experience for expectant mothers, transforming a potentially risky journey into a positive and fulfilling one.
First Piper 